Sanofi India
Sanofi India Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Sanofi India
Start SIPSanofi India Investment Rating
-
Master Rating:
-
Sanofi India Ltd has an operating revenue of Rs. 2,770.10 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 31% is great, ROE of 48% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 44 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 672 | 692 | 699 | 707 |
| Operating Expenses Qtr Cr | 505 | 510 | 538 | 513 |
| Operating Profit Qtr Cr | 167 | 182 | 161 | 195 |
| Depreciation Qtr Cr | 10 | 10 | 11 | 11 |
| Interest Qtr Cr | 0 | 1 | 0 | 0 |
| Tax Qtr Cr | 60 | 52 | 45 | 87 |
| Net Profit Qtr Cr | 131 | 131 | 120 | 238 |
Sanofi India Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 1
- Bearish Moving Average
- ___
- 15
- 20 Day
- 5669.64
- 50 Day
- 5644.2
- 100 Day
- 5706.97
- 200 Day
- 5985.54
- 20 Day
- 5722.31
- 50 Day
- 5581.1
- 100 Day
- 5642.98
- 200 Day
- 5918.9
Sanofi India Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 5644.9 |
| Second Resistance | 5662.3 |
| Third Resistance | 5684.75 |
| RSI | 42.89 |
| MFI | 10.34 |
| MACD Single Line | 35.33 |
| MACD | 13.27 |
| Support | |
|---|---|
| First Resistance | 5605.05 |
| Second Resistance | 5582.6 |
| Third Resistance | 5565.2 |
Sanofi India Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 38,914 | 2,802,975 | 72.03 |
| Week | 17,123 | 1,228,547 | 71.75 |
| 1 Month | 17,435 | 952,844 | 54.65 |
| 6 Month | 19,049 | 1,217,991 | 63.94 |
Sanofi India Result Highlights
Sanofi India Synopsis
NSE-Medical-Generic Drugs
Sanofi India is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2770.10 Cr. and Equity Capital is Rs. 23.00 Cr. for the Year ended 31/12/2022. Sanofi India Ltd. is a Public Limited Listed company incorporated on 02/05/1956 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1956PLC009794 and registration number is 009794.| Market Cap | 12,929 |
| Sales | 2,770 |
| Shares in Float | 0.92 |
| No of funds | 157 |
| Yield | 3.46 |
| Book Value | 10.12 |
| U/D Vol ratio | 1 |
| LTDebt / Equity | |
| Alpha | -0.11 |
| Beta | 0.2 |
Sanofi India
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 60.4% | 60.4% | 60.4% | |
| Mutual Funds | 9.4% | 9.45% | 10.03% | |
| Insurance Companies | 9.82% | 8.82% | 8.56% | |
| Foreign Portfolio Investors | 6.99% | 8.26% | 8.71% | |
| Financial Institutions/ Banks | ||||
| Individual Investors | 9.13% | 8.81% | 7.92% | |
| Others | 4.26% | 4.26% | 4.38% |
Sanofi India Management
| Name | Designation |
|---|---|
| Mr. Aditya Narayan | Chairman |
| Mr. Rajaram Narayanan | Managing Director |
| Mr. Cherian Mathew | Whole Time Director |
| Mr. Vaibhav Karandikar | WholeTime Director & CFO |
| Mr. Charles Billard | Non Executive Director |
| Mr. Marc Antoine Lucchini | Non Executive Director |
| Ms. Usha Thorat | Independent Director |
| Mr. Rahul Bhatnagar | Independent Director |
Sanofi India Forecast
Price Estimates
Sanofi India FAQs
What is Share Price of Sanofi India ?
Sanofi India share price is ₹5613 As on 30 March, 2023 | 23:49
What is the Market Cap of Sanofi India ?
The Market Cap of Sanofi India is ₹12928.6 Cr As on 30 March, 2023 | 23:49
What is the P/E ratio of Sanofi India ?
The P/E ratio of Sanofi India is 20.8 As on 30 March, 2023 | 23:49
What is the PB ratio of Sanofi India ?
The PB ratio of Sanofi India is 10.1 As on 30 March, 2023 | 23:49